BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 23580231)

  • 1. SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion.
    Chen XW; Wang H; Bajaj K; Zhang P; Meng ZX; Ma D; Bai Y; Liu HH; Adams E; Baines A; Yu G; Sartor MA; Zhang B; Yi Z; Lin J; Young SG; Schekman R; Ginsburg D
    Elife; 2013 Apr; 2():e00444. PubMed ID: 23580231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opening up new fronts in the fight against cholesterol.
    Debose-Boyd RA; Horton JD
    Elife; 2013 Apr; 2():e00663. PubMed ID: 23580362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of protein secretion by abrogating receptor-coat interactions during ER export.
    Gomez-Navarro N; Maldutyte J; Poljak K; Peak-Chew SY; Orme J; Bisnett BJ; Lamb CH; Boyce M; Gianni D; Miller EA
    Proc Natl Acad Sci U S A; 2022 Aug; 119(31):e2202080119. PubMed ID: 35901214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE.
    Ason B; van der Hoorn JW; Chan J; Lee E; Pieterman EJ; Nguyen KK; Di M; Shetterly S; Tang J; Yeh WC; Schwarz M; Jukema JW; Scott R; Wasserman SM; Princen HM; Jackson S
    J Lipid Res; 2014 Nov; 55(11):2370-9. PubMed ID: 25258384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation.
    Tavori H; Fan D; Blakemore JL; Yancey PG; Ding L; Linton MF; Fazio S
    Circulation; 2013 Jun; 127(24):2403-13. PubMed ID: 23690465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen has a unique SEC24 preference for efficient export from the endoplasmic reticulum.
    Lu CL; Ortmeier S; Brudvig J; Moretti T; Cain J; Boyadjiev SA; Weimer JM; Kim J
    Traffic; 2022 Jan; 23(1):81-93. PubMed ID: 34761479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the function and homeostasis of PCSK9: reciprocal interaction with LDLR and additional lipid effects.
    Tavori H; Rashid S; Fazio S
    Atherosclerosis; 2015 Feb; 238(2):264-70. PubMed ID: 25544176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kv1.3 contains an alternative C-terminal ER exit motif and is recruited into COPII vesicles by Sec24a.
    Spear JM; Koborssy DA; Schwartz AB; Johnson AJ; Audhya A; Fadool DA; Stagg SM
    BMC Biochem; 2015 Jul; 16():16. PubMed ID: 26156069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration.
    Zaid A; Roubtsova A; Essalmani R; Marcinkiewicz J; Chamberland A; Hamelin J; Tremblay M; Jacques H; Jin W; Davignon J; Seidah NG; Prat A
    Hepatology; 2008 Aug; 48(2):646-54. PubMed ID: 18666258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased APOE-containing HDL subfractions and cholesterol efflux capacity of serum in mice lacking Pcsk9.
    Choi S; Aljakna A; Srivastava U; Peterson BR; Deng B; Prat A; Korstanje R
    Lipids Health Dis; 2013 Jul; 12():112. PubMed ID: 23883163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A missense mutation in the Arabidopsis COPII coat protein Sec24A induces the formation of clusters of the endoplasmic reticulum and Golgi apparatus.
    Faso C; Chen YN; Tamura K; Held M; Zemelis S; Marti L; Saravanan R; Hummel E; Kung L; Miller E; Hawes C; Brandizzi F
    Plant Cell; 2009 Nov; 21(11):3655-71. PubMed ID: 19933202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9.
    van der Tuin SJ; Kühnast S; Berbée JF; Verschuren L; Pieterman EJ; Havekes LM; van der Hoorn JW; Rensen PC; Jukema JW; Princen HM; Willems van Dijk K; Wang Y
    J Lipid Res; 2015 Nov; 56(11):2085-93. PubMed ID: 26342106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Sirt1 activator SRT3025 provides atheroprotection in Apoe-/- mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression.
    Miranda MX; van Tits LJ; Lohmann C; Arsiwala T; Winnik S; Tailleux A; Stein S; Gomes AP; Suri V; Ellis JL; Lutz TA; Hottiger MO; Sinclair DA; Auwerx J; Schoonjans K; Staels B; Lüscher TF; Matter CM
    Eur Heart J; 2015 Jan; 36(1):51-9. PubMed ID: 24603306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic overexpression of idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways.
    Sasaki M; Terao Y; Ayaori M; Uto-Kondo H; Iizuka M; Yogo M; Hagisawa K; Takiguchi S; Yakushiji E; Nakaya K; Ogura M; Komatsu T; Ikewaki K
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1171-8. PubMed ID: 24675665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cellular trafficking of the secretory proprotein convertase PCSK9 and its dependence on the LDLR.
    Nassoury N; Blasiole DA; Tebon Oler A; Benjannet S; Hamelin J; Poupon V; McPherson PS; Attie AD; Prat A; Seidah NG
    Traffic; 2007 Jun; 8(6):718-32. PubMed ID: 17461796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Function and distribution of circulating human PCSK9 expressed extrahepatically in transgenic mice.
    Luo Y; Warren L; Xia D; Jensen H; Sand T; Petras S; Qin W; Miller KS; Hawkins J
    J Lipid Res; 2009 Aug; 50(8):1581-8. PubMed ID: 19060325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced VLDL clearance in Apoe(-/-)Npc1(-/-) mice is associated with increased Pcsk9 and Idol expression and decreased hepatic LDL-receptor levels.
    Ishibashi M; Masson D; Westerterp M; Wang N; Sayers S; Li R; Welch CL; Tall AR
    J Lipid Res; 2010 Sep; 51(9):2655-63. PubMed ID: 20562239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vesicle-mediated export from the ER: COPII coat function and regulation.
    D'Arcangelo JG; Stahmer KR; Miller EA
    Biochim Biophys Acta; 2013 Nov; 1833(11):2464-72. PubMed ID: 23419775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRP94 Regulates Circulating Cholesterol Levels through Blockade of PCSK9-Induced LDLR Degradation.
    Poirier S; Mamarbachi M; Chen WT; Lee AS; Mayer G
    Cell Rep; 2015 Dec; 13(10):2064-71. PubMed ID: 26628375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B subviral envelope particles use the COPII machinery for intracellular transport via selective exploitation of Sec24A and Sec23B.
    Zeyen L; Döring T; Stieler JT; Prange R
    Cell Microbiol; 2020 Jun; 22(6):e13181. PubMed ID: 32017353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.